|
시장보고서
상품코드
2052592
재택 주입 요법 시장 : 제품 유형별, 용도별, 지역별Home Infusion Therapy Market, By Product Type, By Application, By Geography |
||||||
재택 주입 요법 시장은 2026년에 280억 1,000만 달러로 추정되며, 2033년까지 449억 8,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 7.0%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 280억 1,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 7.00% | 2033년 시장 규모 예측: | 449억 8,000만 달러 |
재택 주입 요법은 정맥 내(IV) 장치 또는 IV 카테터를 사용하여 환자의 집에서 약물이나 영양분을 혈류에 직접 투여하는 치료법입니다. 이를 통해 환자는 의료기관을 방문하지 않고도 집에서 편안하게 다양한 치료를 받을 수 있습니다. 암, 울혈성 심부전, 면역요법, 당뇨병 등 많은 만성질환과 병증들이 재택 주입 요법으로 치료되는 사례가 증가하고 있습니다. 고령 인구의 증가, 만성 질환의 유병률 증가, 입원 치료 대비 비용 경쟁력, 재택 수액기기의 기술 발전 등이 이 시장을 이끄는 주요 요인으로 작용하고 있습니다. 그러나 숙련된 의료인력의 부족, 엄격한 규제, 그리고 보험금 지급에 대한 문제가 시장을 어느 정도 억제할 수 있습니다.
시장 역학
세계 재택 주입 요법 시장은 고령 인구 증가, 만성 질환 유병률 증가, 입원 치료 대비 비용 경쟁력, 재택 수액 치료 장비의 기술 발전 등의 요인에 의해 주도되고 있습니다. 세계보건기구(WHO)에 따르면, 세계 고령인구는 2015년 9억 명에서 2050년까지 약 15억 명에 달할 것으로 예측하고 있습니다. 또한, 암, 당뇨병, 울혈성 심부전, 자가면역질환 등 만성질환의 증가로 인해 재택 주입 요법에 대한 수요가 증가하고 있습니다. 재택 주입 요법을 통해 환자는 집에서 편안하게 치료를 받을 수 있으며, 입원에 따른 고비용을 절감할 수 있습니다. 그러나 숙련된 의료 인력 부족, 엄격한 규제 및 정책, 특히 개발도상국에서의 의료비 상환 정책 등의 문제가 시장 성장의 걸림돌로 작용하고 있습니다. 일부 국가에서의 낮은 인지도도 시장 성장을 저해하는 요인으로 작용하고 있습니다. 그럼에도 불구하고, 지속적인 연구와 새로운 재택 수액 치료 기기의 도입으로 시장 관계자들에게 성장 기회가 창출될 것으로 예상됩니다.
본 조사의 주요 특징
- 이 조사에서는 각 부문의 잠재적인 수익 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 다음과 같은 매개 변수를 기반으로 세계 재택 주입 요법 시장의 주요 기업 프로파일을 작성합니다 : 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과 및 전략.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 이 세계 재택 주입 요법 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 재택 주입 요법 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 재택 주입 요법 시장 : 제품 유형별, 2021-2033년
제5장 세계의 재택 주입 요법 시장 : 용도별, 2021-2033년
제6장 세계의 재택 주입 요법 시장 : 지역별, 2021-2033년
제7장 경쟁 구도
제8장 기회 분석
제9장 참고문헌 및 조사 방법
KSMHome Infusion Therapy Market is estimated to be valued at USD 28.01 Bn in 2026 and is expected to reach USD 44.98 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 28.01 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 7.00% | 2033 Value Projection: | USD 44.98 Bn |
Home infusion therapy refers to the delivery of medications and nutrients directly into a patient's bloodstream at home, through an intravenous (IV) device or IV catheter. It allows patients to receive various therapies in the comfort of their own home, instead of visiting a healthcare facility. A number of chronic diseases and conditions, such as cancer, congestive heart failure, immunotherapy, and diabetes, are increasingly being treated through home infusion therapy. Growing geriatric population, increasing prevalence of chronic diseases, cost competitiveness compared to hospitalization, and technological advancements in home infusion devices are the major factors driving this market. However, lack of skilled healthcare professionals, stringent regulations, and reimbursement issues may restrain the market to a certain extent.
Market Dynamics
The global home infusion therapy market is driven by factors such as growing geriatric population, increasing prevalence of chronic diseases, cost competitiveness as compared to hospitalization, and technological advancements in home infusion devices. As per WHO, the global geriatric population is expected to reach approximately 1.5 billion by 2050, up from 900 million in 2015. Moreover, rising cases of chronic conditions such as cancer, diabetes, congestive heart failure, and autoimmune diseases are increasing the demand for home infusion therapy. Home infusion therapy allows patients to receive treatment in comfort of their home, avoiding high costs associated with hospital stays. However, lack of skilled healthcare professionals especially in developing regions, stringent regulations, and issues regarding reimbursement policies pose a challenge to market growth. Lack of awareness in some countries also restrains the market growth. Nevertheless, ongoing research and introduction of new home infusion therapy devices are expected to create growth opportunities for market players.
Key Features of the Study
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global home infusion therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Option Care Health, Inc., UK HomeCare Services Ltd., Coram LLC, Pfizer Inc., Medtronic, CareCentrix Inc. , PharMerica Corporation.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global home infusion therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global home infusion therapy market.
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Infusion Pumps
- Ambulatory Infusion Pumps
- Insulin Pumps
- Syringe Pumps
- Elastomeric Pumps
- Patient Controlled Analgesics (PCA)
- Volumetric Pumps
- Intravenous Set
- IV Cannulas
- Needleless Connectors
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Chemotherapy
- Diabetes
- Hydration Therapy
- Pain Management
- Post-transplant Therapies
- Parenteral Nutrition Therapy
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Baxter International Inc.
- B. Braun Melsungen AG
- Fresenius Kabi AG
- Smiths Medical
- CareCentrix, Inc.
- Coram CVS/specialty infusion services
- Option Care Health Inc.
- CVS Health
- UnitedHealth Group (Optum)
- McKesson Corporation
- PharMerica Corporation
- BioScrip, Inc.
- MedicoRx Specialty Pharmacy
- Infusystem
- Diplomat Pharmacy, Inc.
- Accredo Health Group, Inc.
- Healix, Inc.
- PromptCare Home Infusion
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Home Infusion Therapy Market, By Product Type, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Infusion Pumps
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Ambulatory Infusion Pumps
- Insulin Pumps
- Syringe Pumps
- Elastomeric Pumps
- Patient Controlled Analgesics (PCA)
- Volumetric Pumps
- Intravenous Set
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- IV Cannulas
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Pembrolizumab (Phase 3)
- Needleless Connectors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Home Infusion Therapy Market, By Application, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Chemotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Diabetes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Hydration Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Pain Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Post-transplant Therapies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Parenteral Nutrition Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Home Infusion Therapy Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
7. Competitive Landscape
- Company Profiles
- Baxter International Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- B. Braun Melsungen AG
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Fresenius Kabi AG
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Smith's Medical
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CareCentrix, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Coram CVS/specialty infusion services
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Option Care Health Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CVS Health
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- UnitedHealth Group (Optum)
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- McKesson Corporation
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- PharMerica Corporation
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BioScrip, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- MedicoRx Specialty Pharmacy
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Infusystem
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Diplomat Pharmacy, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Accredo Health Group, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Healix, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- PromptCare Home Infusion
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Baxter International Inc.
8. Wheel of Fortune
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
9. Reference and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
